Utah Medical Products (UTMD) Profit After Tax (2010 - 2026)

Utah Medical Products' Profit After Tax history runs 17 years deep, the most recent figure standing at $2.1 million for Q1 2026.

• On a quarterly basis, Profit After Tax fell 44.11% year-over-year to $2.1 million in Q1 2026; TTM through Mar 2026 was $10.3 million, a 24.36% decrease from a year earlier, with the FY2025 full-year figure at $13.8 million, up 9.13% from the prior year.
• Profit After Tax eased to $2.1 million in Q1 2026 per UTMD's latest filing, from $2.6 million in the prior quarter.
• Across five years, Profit After Tax topped out at $4.6 million in Q4 2022 and bottomed at $2.1 million in Q1 2026.
• The 5-year median for Profit After Tax is $3.8 million (2025), against an average of $3.6 million.
• Across the five-year window, Profit After Tax increased 19.76% in 2022 and sank 44.11% in 2026, its largest moves.
• Year by year, Profit After Tax stood at $4.6 million in 2022, then fell by 5.88% to $4.3 million in 2023, then sank by 32.31% to $2.9 million in 2024, then slipped by 11.61% to $2.6 million in 2025, then fell by 18.09% to $2.1 million in 2026.
• Per Business Quant, the three latest UTMD Profit After Tax figures stand at $2.1 million (Q1 2026), $2.6 million (Q4 2025), and $2.6 million (Q3 2025).